GSK recalls weight-loss drug Alli in U.S. after tampering

by Reuters
Thursday, 27 March 2014 13:25 GMT

LONDON, March 27 (Reuters) - GlaxoSmithKline is recalling all supplies of its non-prescription weight-loss drug Alli in the United States and Puerto Rico, the company said on Thursday, after reports that some bottles had been tampered with.

The British group, which believes that some supplies may not contain authentic Alli, is working with the U.S. Food and Drug Administration on the retailer-level recall.

News of the tampering first emerged on Wednesday.

GSK has received inquiries from consumers in seven U.S. states about bottles containing tablets and capsules that were not Alli, with a range of tablets and capsules of various shapes and colours reported. Alli is a turquoise-blue capsule. (Reporting by Ben Hirschler; Editing by David Goodman)

Latest News
Comments Close
GSK recalls weight-loss drug Alli in U.S. after tampering

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of the Thomson Reuters Foundation. For more information see our Acceptable Use Policy.

comments powered by Disqus